Principal Investigators - Dr. Kathleen M. Powis, MD, MPH, MBA | Dr. Jennifer Jao, MD, MPH | Dr. Joseph Makhema, MB.ChB, FRCP
Study Objectives
Primary Study Aims
Principal Investigators - Dr. Kathleen M. Powis, MD, MPH, MBA | Dr. Jennifer Jao, MD, MPH | Dr. Joseph Makhema, MB.ChB, FRCP
Study Objectives
Primary Study Aims
Principal Investigator - Dr. Scott Dryden-Peterson MD, MSc
Thabatse is a prospective cohort study which aims to evaluate the risk factors for cancer and describe the response to treatment for patients who are HIV positive and not on Antiretroviral Therapy (ART) and those on ART.
Study Objectives
The primary aims are to evaluate the important risk factors for cancer in Botswana (including HIV) and describe the response to treatment for patients without HIV, with HIV but not yet on HAART, and those with HIV and on HAART.
Principal Investigator - Dr. Rebecca Luckett, MD, MPH
Name of the Study: Evaluation of cervical cancer screening algorithms using primary high risk human papillomavirus (HPV) in Gaborone and South East District, Botswana
Completed: Recruitment of 300 women living with HIV in Gaborone, and one year follow-up of this cohort.
On-going: Recruitment of a new cohort of 3000 women in South East District is currently underway. 50% of the cohort will be women living with HIV.
Study Objectives: The group aims to improve the diagnosis and treatment of the four major HIV-associated fungal infections of public health importance and to ensure that these improvements are made widely available to populations most commonly affected in Africa (Democratic Republic of Congo, Mozambique, Guinea, Malawi, Botswana, South Africa), and South East Asia (Vietnam). The group brings together leading academic rese
Principal Investigator - Melanie Dubois, MD
Study Objectives:
Study Objectives:
The primary aim of this study is to evaluate the sensitivity and specificity of the Abbot ANC panel and its usability by trained Healthcare Professionals in a non-laboratory setting.
Principal Investigator: Dr. Ellen Caniglia, ScD
Study Objectives
Principal Investigator - Professor Mosepele Mosepele MD, MSc, | Laura Bogart PhD
Study Objectives:
Principal Investigators - Professor Mosepele Mosepele MD, MSc | Tendani Gaolathe BS, MD | Kathleen Wirth Hurwitz
Principal Investigator - Dr. Chelsea Morroni, MD, MPH, PhD
Principal Investigator: Ellen Caniglia, ScD
Study iron, folic acid and multiple micronutrient supplementation and adverse birth outcomes in Botswana began in 2020.
Principal Investigator - Dr. Kathleen Powis, MD, MPH
Specific Aim 1: Define TB-related and TB-independent risk factors if morbidity and mortality in the first year of life among BCG vaccinated HE and HUU infants enrolled in the Karabo Study and a second ongoing study in Cape Town, South Africa, the InFANT Study (Innate Factors Associated with Nursing Transmission; funded by Canadian Institutes of Health Reseach), using multivariable logistic regression analysis.
Primary Objectives
Principal Investigator - Lucy Mupfumi, PhD
Study Objectives
Principal Investigators - Professor Mosepele Mosepele, MD, MSc | Laura Bogart, PhD
Principal Investigators: Prof. Sikhulile Moyo and Dr Shahin Lockman
Study Objectives: To evaluate the feasibility of testing wastewater from both urban and village settings in Botswana for;
Principal Investigator: Chelsea Morroni, MPH, MPhil, PhD, MBChB, DTM&H, DFSRH
Study Objectives:
Principal Investigator - Dr. Shahin Lockman MD, MPH | Dr. Adam Cassidy
Principal Investigator - Dr. Shahin Lockman MD, MPH
Primary Objectives: To provide access to age appropriate formulations of dolutegravir (DTG), either as Tivicay or as fixed dose combination (FDC) abacavir/dolutegravir/lamivudine (ABC/DTG/3TC), in an open-label protocol to eligible subjects who have completed the P1093 or IMPAACT 2019 parent studies.
Principal Investigator: Gaerolwe R. Masheto, MD
Study Objectives: